Renal Denervation (RDN) treatment is being studied in a clinical trial to learn whether renal denervation is a safe and effective treatment option to lower blood pressure for certain patients with uncontrolled hypertension.
If you are selected to be part of this trial, you must:
You should discuss the estimate of costs with your study doctor. Since this is part of a clinical trial, Medtronic will not charge for the device used in this study. Furthermore, you will not be charged for the cost of collecting the data for this study and other clinic visits and diagnostic tests done solely for the purposes of this study.
Patients with uncontrolled hypertension may qualify to take part in the clinical trial. If chosen for the trial, more testing will be done to determine eligibility. Only your study doctor can decide if you are a good candidate for the clinical trial.
If the study doctor decides you are eligible, it is up to you to decide if you wish to participate in this study.